OMUFA - Screening Non-Sterile OTC Monograph Products for Microbial Contamination
Forecast overview
- Subagency
- FDA
- NAICS
- 541714
- Program office
- CDER ACQUISITION
OMUFA - A study will be designed to evaluate non-sterile, aqueous based, OTC monographdrugs for microbial contamination. This will enhance FDA's surveillance of OTC monograph products andpotentially reduce the incidence of adverse events.
Related federal terms
- NAICS — North American Industry Classification System
Acquisition timeline
- Last verified on RFPCapture
- 2026-08-31
- Estimated solicitation
- 6/2025 (agency estimate)
- Estimated award
- 11/2025 (agency estimate)
- Expected period of performance end
- 11/2025 (agency estimate)
Market context
- NAICS market
- NAICS 541714
Action links
Track this forecast in CaptureIQ
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31